PINK.V - Perimeter Medical Imaging AI, Inc.
| Previous Close | 1.8500 |
| Open | 1.8500 |
| Bid | 1.8200 x N/A |
| Ask | 1.8300 x N/A |
| Day's Range | 1.8000 - 1.8700 |
| 52 Week Range | 1.1000 - 2.1400 |
| Volume | |
| Avg. Volume | 30,814 |
| Market Cap | 117.976M |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.1700 |
| Earnings Date | Aug 22, 2023 - Aug 28, 2023 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 5.49 |
CNW GroupPerimeter Medical Imaging AI Announces CEO Transition and New Member of the Board of Directors
(TSXV: PINK) (OTC: PYNKF) (FSE: 4PC) – Perimeter Medical Imaging AI, Inc. ("Perimeter" or the "Company") – a commercial-stage medical technology company – announced that Jeremy Sobotta has resigned as Chief Executive Officer of the Company, effective June 15, 2023, for personal reasons.
CNW GroupPerimeter Medical Imaging AI Reports First Quarter 2023 Financial Results and Provides Corporate Update
Perimeter Medical Imaging AI, Inc. (TSXV: PINK) (OTC: PYNKF) (FSE: 4PC) ("Perimeter" or the "Company") – a medical technology company driven to transform cancer surgery with ultra-high-resolution, real-time, advanced imaging tools to address high unmet medical needs – today reported financial results for its first quarter ended March 31, 2023 and provided a corporate update.
CNW GroupPerimeter Medical Imaging AI Announces Resignation of Director
(TSXV: PINK) (OTC: PYNKF) (FSE: 4PC) – Perimeter Medical Imaging AI, Inc. ("Perimeter" or the "Company") – a commercial-stage medical technology company – announced that Dr. Anthony Holler has resigned as a director of the Company, effective immediately, for personal reasons.
CNW GroupPerimeter Medical Imaging AI Announces Conference Call and Webcast to Discuss First Quarter 2023 Financial Results and Provide Corporate Update
Perimeter Medical Imaging AI, Inc. (TSXV: PINK) (OTC: PYNKF) (FSE: 4PC) ("Perimeter" or the "Company") – a commercial-stage medical technology company – announced it will report its first quarter 2023 financial and operating results after the close of U.S. financial markets on Thursday, May 25, 2023.
CNW GroupPerimeter Medical Imaging AI Announces Initiation of Additional Clinical Trial Site at Baptist MD Anderson Cancer Center in Jacksonville, FL
(TSXV: PINK) (OTC: PYNKF) (FSE: 4PC) – Perimeter Medical Imaging AI, Inc. ("Perimeter" or the "Company") – a commercial-stage medical technology company – announced the initiation of an additional clinical trial site at Baptist MD Anderson Cancer Center in Jacksonville, FL under the direction of Laila Samiian, MD, FACS.
CNW GroupPerimeter Medical Imaging AI Announces Symposium and Its Participation at ASBrS 2023
(TSXV: PINK) (OTC: PYNKF) (FSE: 4PC) – Perimeter Medical Imaging AI, Inc. ("Perimeter" or the "Company") – a commercial-stage medical technology company – announced that it will host an educational symposium featuring the Perimeter S-Series OCT technology at the upcoming annual meeting of the American Society of Breast Surgeons (ASBrS) taking place April 26-30, 2023 at the John B. Hynes Veterans Memorial Convention Center in Boston, MA.
- News Direct
Breast Surgical Oncologist discusses game-changing technology in Perimeter S-Series OCT system
Natalie Stoberman is joined by Dr Amelia Tower, a Texas-based breast surgical oncologist and collaborator with Perimeter Medical Imaging AI, to discuss her recently published white paper based on c...
CNW GroupPerimeter Medical Imaging AI Announces First Commercial Placement of Perimeter S-Series OCT in the State of Utah
Perimeter Medical Imaging AI, Inc. (TSXV: PINK) (OTC: PYNKF) (FSE: 4PC) ("Perimeter" or the "Company") – a medical technology company driven to transform cancer surgery with ultra-high-resolution, real-time, advanced imaging tools to address high unmet medical needs – announced the first commercial placement of its flagship Perimeter S-Series OCT system in the state of Utah, which will be used under the direction of breast surgeon, Jennifer J. Tittensor, MD, FACS.
CNW GroupPerimeter Medical Imaging AI to Present at the 2023 Bloom Burton & Co. Healthcare Investor Conference
Perimeter Medical Imaging AI, Inc. (TSXV: PINK) (OTC: PYNKF) (FSE: 4PC) ("Perimeter" or the "Company") – a medical technology company driven to transform cancer surgery with ultra-high-resolution, real-time, advanced imaging tools to address high unmet medical needs – announced it will participate in one-on-one investor meetings and host a company presentation at the 2023 Bloom Burton & Co. Healthcare Investor Conference to be held in Toronto, Ontario from April 25-26, 2023.
CNW GroupPerimeter Medical Imaging AI Reports 2022 Financial Results and Provides Corporate Update
Perimeter Medical Imaging AI, Inc. (TSXV: PINK) (OTC: PYNKF) (FSE: 4PC) ("Perimeter" or the "Company") – a medical technology company driven to transform cancer surgery with ultra-high-resolution, real-time, advanced imaging tools to address high unmet medical needs – today reported financial results for the year ended December 31, 2022 and provided a corporate update.
CNW GroupPerimeter Medical Imaging AI Announces Conference Call and Webcast to Discuss 2022 Financial Results and Provide Corporate Update
Perimeter Medical Imaging AI, Inc. (TSXV: PINK) (OTC: PYNKF) (FSE: 4PC) ("Perimeter" or the "Company") – a medical technology company driven to transform cancer surgery with ultra-high-resolution, real-time, advanced imaging tools to address high unmet medical needs – announced it will report its financial and operating results for the year ended December 31, 2022 after the close of U.S. financial markets on Tuesday, April 11, 2023.
CNW GroupPerimeter Medical Imaging AI Announces Publication of New Clinical Evidence Featuring Case Studies from Commercial Use of Perimeter S-Series OCT
(TSXV: PINK) (OTC: PYNKF) (FSE: 4PC) – Perimeter Medical Imaging AI, Inc. ("Perimeter" or the "Company") – a commercial-stage medical technology company – announced the publication of a new white paper entitled "Use of adjunct wide-field optical coherence tomography to visualize margins during breast conserving surgery for ductal carcinoma in situ: a case series," which features three case studies from the commercial use of its innovative Perimeter S-Series OCT technology.
CNW GroupPerimeter Medical Imaging AI Announces Its Participation at SSO 2023 Including An Industry Spotlight Session Featuring Perimeter S-Series OCT
(TSXV: PINK) (OTC: PYNKF) (FSE: 4PC) – Perimeter Medical Imaging AI, Inc. ("Perimeter" or the "Company") – a commercial-stage medical technology company – announced that it will participate in the upcoming International Conference on Surgical Cancer Care hosted by the Society of Surgical Oncology (SSO), with a spotlight presentation in the HUB Theater and featuring demos on the S-Series OCT device in the HUB exhibit hall.
CNW GroupPerimeter Medical Imaging AI Announces Its Proprietary AI Technology is Featured in an Interactive Museum Exhibit on Artificial Intelligence
(TSXV: PINK) (OTC: PYNKF) (FSE: 4PC) – Perimeter Medical Imaging AI, Inc. ("Perimeter" or the "Company") – a commercial-stage medical technology company – announced that its investigational AI technology is being featured in a museum exhibit entitled "Artificial Intelligence: Your Mind & The Machine," which is open now through May 6, 2023 at the Museum of Science & History (MoSH) in Memphis, TN.
Business WirePerimeter Medical Imaging AI Announces Leadership Changes with the Appointment of Suzanne Foster as Chair of its Board of Directors
TORONTO & DALLAS, January 17, 2023--(TSX-V: PINK) (OTC: PYNKF) (FSE: 4PC) – Perimeter Medical Imaging AI, Inc. ("Perimeter" or the "Company") – a commercial-stage medical technology company – today reported leadership changes, including the appointment of Suzanne Foster as Chair of its Board of Directors, effective immediately.
Business WirePerimeter Medical Imaging AI Announces Completion of Two New Commercial Placements of Perimeter S-Series OCT
TORONTO & DALLAS, January 10, 2023--Perimeter Medical Imaging AI, Inc. (TSX-V: PINK) (OTC: PYNKF) (FSE: 4PC)("Perimeter" or the "Company") – a commercial-stage medical technology company – today reported two new commercial installations of its flagship Perimeter S-Series OCT system, which were completed prior to year-end.
- Business Wire
Perimeter Medical Imaging AI Announces Publication of Peer-Reviewed Journal Article Validating Potential Use of Wide-Field Optical Coherence Tomography (WF-OCT) in Head and Neck Surgeries
TORONTO & DALLAS, December 05, 2022--Perimeter Medical Imaging AI, Inc. (TSX-V: PINK)(OTC: PYNKF) (FSE: 4PC) ("Perimeter" or the "Company") announced the publication of a peer-reviewed research article in JAMA Otolaryngology—Head and Neck Surgery. The study’s findings validate the further exploration of the use of Perimeter’s wide-field Optical Coherence Tomography (WF-OCT) technology to visualize margins during head and neck surgeries.
Business WirePerimeter Medical Imaging AI Reports Third Quarter 2022 Financial Results and Provides Corporate Update
TORONTO & DALLAS, November 15, 2022--Perimeter Medical Imaging AI, Inc. (TSX-V: PINK) (OTC: PYNKF) (FSE: 4PC) ("Perimeter" or the "Company") – a medical technology company driven to transform cancer surgery with ultra-high-resolution, real-time, advanced imaging tools to address high unmet medical needs – today reported financial results for its third quarter ended September 30, 2022 and provided a corporate update.
Business WirePerimeter Medical Imaging AI Announces Follow-On Commercial Placement of Perimeter S-Series OCT within National Healthcare Provider System at New Hospital Site
TORONTO & DALLAS, November 15, 2022--Perimeter Medical Imaging AI, Inc. (TSX-V: PINK)(OTC: PYNKF) (FSE: 4PC) announced another commercial placement of its flagship Perimeter S-Series OCT system at a second hospital within one of the largest healthcare networks in North Texas, which is part of a major national healthcare system. Perimeter is a medical technology company driven to transform cancer surgery with ultra-high-resolution, real-time, advanced imaging tools to address high unmet medical n
Business WirePerimeter Medical Imaging AI Announces Conference Call and Webcast to Discuss Third Quarter 2022 Financial Results and Provide Corporate Update
TORONTO & DALLAS, November 08, 2022--Perimeter Medical Imaging AI, Inc. (TSX-V: PINK)(OTC: PYNKF) (FSE: 4PC) ("Perimeter" or the "Company") – a medical technology company driven to transform cancer surgery with ultra-high-resolution, real-time, advanced imaging tools to address high unmet medical needs – today announced it will report its third quarter 2022 financial and operating results after the close of U.S. financial markets on Tuesday, November 15, 2022.
Business WirePerimeter Medical Imaging AI Announces Voting Results from 2022 Annual and Special Meeting of Shareholders
TORONTO & DALLAS, November 07, 2022--Perimeter Medical Imaging AI, Inc. (TSX-V: PINK) (OTC: PYNKF) (FSE: 4PC) ("Perimeter" or the "Company") – a medical technology company driven to transform cancer surgery with ultra-high-resolution, real-time, advanced imaging tools to address high unmet medical needs, announced the results of its 2022 annual and special meeting of shareholders (the "Meeting") held on October 27, 2022.
- Newsfile
Perimeter Medical Imaging AI to Present at LD Micro Main Event XV Investor Conference in Los Angeles, CA (Oct. 25-27, 2022)
Toronto, Ontario and Dallas, Texas--(Newsfile Corp. - October 18, 2022) - Perimeter Medical Imaging AI, Inc. (TSXV: PINK) (OTC: PYNKF) (FSE: 4PC) - a medical technology company driven to transform cancer surgery with ultra-high-resolution, real-time, advanced imaging tools to address high unmet medical need, today announced management's participation in the LD Micro Main Event XV conference being held from October 25-27, 2022 at the Luxe Sunset Boulevard Hotel in Bel Air, California.Jeremy Sobot
Business WirePerimeter Medical Imaging AI Hosts Two Poster Presentations at the College of American Pathologists 2022 Annual Meeting
TORONTO & DALLAS, October 12, 2022--Perimeter Medical Imaging AI, Inc. (TSX-V:PINK) (OTC:PYNKF) (FSE:4PC) – a medical technology company driven to transform cancer surgery with ultra-high-resolution, real-time, advanced imaging tools to address high unmet medical needs – announced two poster presentations at the Annual Meeting of the College of American Pathologists 2022 (CAP22), which took place October 8 to 11, 2022 in New Orleans, LA. The research presented validates the potential use of Peri
Business WirePerimeter Medical Imaging AI Graduates to Tier 1 of the TSX-V
TORONTO & DALLAS, October 03, 2022--Perimeter Medical Imaging AI, Inc. (TSX-V:PINK)(OTC:PYNKF) (FSE:4PC) ("Perimeter" or the "Company") – a medical technology company driven to transform cancer surgery with ultra-high-resolution, real-time, advanced imaging tools to address high unmet medical needs – announces that the TSX Venture Exchange (TSX-V) has approved its application to graduate from a Tier 2 Issuer to a Tier 1 Issuer. Tier 1 is reserved for senior TSX-V companies with the most signific
Business WirePerimeter Medical Imaging AI Announces Commercial Placement of Perimeter S-Series OCT within National Healthcare Provider System
TORONTO & DALLAS, September 29, 2022--Perimeter Medical Imaging AI, Inc. (TSX-V:PINK) (OTC:PYNKF) (FSE:4PC) announced the commercial placement of its flagship Perimeter S-Series OCT system at a hospital that is part of a major national healthcare system and one of the largest healthcare networks in North Texas. Perimeter is a medical technology company driven to transform cancer surgery with ultra-high-resolution, real-time, advanced imaging tools to address high unmet medical needs.